FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2918294521> ?p ?o ?g. }

• W2918294521 endingPage "296" @default.
• W2918294521 startingPage "296" @default.
• W2918294521 abstract "The advent of immune checkpoint inhibitors gave rise to a new era in oncology and general medicine. The increasing use of programmed death-1 (PD-1) inhibitors in non-small cell lung cancer and in other malignancies means clinicians have to face up to new challenges in managing immune-related adverse events (irAEs), which often resemble autoimmune diseases. Neurological irAEs represent an emerging toxicity related to immunotherapy, and it is mandatory to know how to monitor, recognize, and manage them, since they can rapidly lead to patient death if untreated. Guidelines for the diagnosis and treatment of these irAEs have been recently published but sharing some of the most unusual clinical cases is crucial, in our opinion, to improve awareness and to optimize the approach for these patients. A literature review on the diagnosis and treatment of immune-related neurotoxicity’s has been conducted starting from the report of four cases of neurological irAEs regarding cases of polyneuropathy, myasthenia gravis, Bell’s palsy, and encephalopathy, all of which occurred in oncological patients receiving PD-1 inhibitors (pembrolizumab and nivolumab) for the treatment of non-oncogene addicted advanced non-small cell lung cancer. The exclusion of other differential diagnoses and the correlation between the suspension of immunotherapy and improvement of symptoms suggest that immunotherapy could be the cause of the neurological disorders reported." @default.
• W2918294521 created "2019-03-11" @default.
• W2918294521 creator A5008746128 @default.
• W2918294521 creator A5017856488 @default.
• W2918294521 creator A5031395312 @default.
• W2918294521 creator A5038987824 @default.
• W2918294521 creator A5040884103 @default.
• W2918294521 creator A5046781912 @default.
• W2918294521 creator A5058513968 @default.
• W2918294521 creator A5058537459 @default.
• W2918294521 creator A5061265768 @default.
• W2918294521 creator A5082117544 @default.
• W2918294521 date "2019-03-01" @default.
• W2918294521 modified "2023-10-17" @default.
• W2918294521 title "PD-1 Inhibitors-Related Neurological Toxicities in Patients with Non-Small-Cell Lung Cancer: A Literature Review" @default.
• W2918294521 cites W1556990476 @default.
• W2918294521 cites W1757407923 @default.
• W2918294521 cites W1990675339 @default.
• W2918294521 cites W2097258429 @default.
• W2918294521 cites W2106852126 @default.
• W2918294521 cites W2107664743 @default.
• W2918294521 cites W2213347440 @default.
• W2918294521 cites W2270309512 @default.
• W2918294521 cites W2308693772 @default.
• W2918294521 cites W2330090180 @default.
• W2918294521 cites W2338423971 @default.
• W2918294521 cites W2345223206 @default.
• W2918294521 cites W2411407183 @default.
• W2918294521 cites W2416888735 @default.
• W2918294521 cites W2428236439 @default.
• W2918294521 cites W2487303921 @default.
• W2918294521 cites W2521728442 @default.
• W2918294521 cites W2532352313 @default.
• W2918294521 cites W2569887568 @default.
• W2918294521 cites W2572174216 @default.
• W2918294521 cites W2616987256 @default.
• W2918294521 cites W2654176753 @default.
• W2918294521 cites W2676820279 @default.
• W2918294521 cites W2747440871 @default.
• W2918294521 cites W2749394429 @default.
• W2918294521 cites W2751866898 @default.
• W2918294521 cites W2755347356 @default.
• W2918294521 cites W2756666776 @default.
• W2918294521 cites W2786816161 @default.
• W2918294521 cites W2904600726 @default.
• W2918294521 cites W3022314034 @default.
• W2918294521 doi "https://doi.org/10.3390/cancers11030296" @default.
• W2918294521 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6468526" @default.
• W2918294521 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30832285" @default.
• W2918294521 hasPublicationYear "2019" @default.
• W2918294521 type Work @default.
• W2918294521 sameAs 2918294521 @default.
• W2918294521 citedByCount "22" @default.
• W2918294521 countsByYear W29182945212019 @default.
• W2918294521 countsByYear W29182945212020 @default.
• W2918294521 countsByYear W29182945212021 @default.
• W2918294521 countsByYear W29182945212022 @default.
• W2918294521 countsByYear W29182945212023 @default.
• W2918294521 crossrefType "journal-article" @default.
• W2918294521 hasAuthorship W2918294521A5008746128 @default.
• W2918294521 hasAuthorship W2918294521A5017856488 @default.
• W2918294521 hasAuthorship W2918294521A5031395312 @default.
• W2918294521 hasAuthorship W2918294521A5038987824 @default.
• W2918294521 hasAuthorship W2918294521A5040884103 @default.
• W2918294521 hasAuthorship W2918294521A5046781912 @default.
• W2918294521 hasAuthorship W2918294521A5058513968 @default.
• W2918294521 hasAuthorship W2918294521A5058537459 @default.
• W2918294521 hasAuthorship W2918294521A5061265768 @default.
• W2918294521 hasAuthorship W2918294521A5082117544 @default.
• W2918294521 hasBestOaLocation W29182945211 @default.
• W2918294521 hasConcept C118552586 @default.
• W2918294521 hasConcept C121608353 @default.
• W2918294521 hasConcept C126322002 @default.
• W2918294521 hasConcept C143998085 @default.
• W2918294521 hasConcept C16568411 @default.
• W2918294521 hasConcept C177713679 @default.
• W2918294521 hasConcept C197934379 @default.
• W2918294521 hasConcept C2776256026 @default.
• W2918294521 hasConcept C2777701055 @default.
• W2918294521 hasConcept C2778621155 @default.
• W2918294521 hasConcept C2780030458 @default.
• W2918294521 hasConcept C2780057760 @default.
• W2918294521 hasConcept C71924100 @default.
• W2918294521 hasConceptScore W2918294521C118552586 @default.
• W2918294521 hasConceptScore W2918294521C121608353 @default.
• W2918294521 hasConceptScore W2918294521C126322002 @default.
• W2918294521 hasConceptScore W2918294521C143998085 @default.
• W2918294521 hasConceptScore W2918294521C16568411 @default.
• W2918294521 hasConceptScore W2918294521C177713679 @default.
• W2918294521 hasConceptScore W2918294521C197934379 @default.
• W2918294521 hasConceptScore W2918294521C2776256026 @default.
• W2918294521 hasConceptScore W2918294521C2777701055 @default.
• W2918294521 hasConceptScore W2918294521C2778621155 @default.
• W2918294521 hasConceptScore W2918294521C2780030458 @default.
• W2918294521 hasConceptScore W2918294521C2780057760 @default.
• W2918294521 hasConceptScore W2918294521C71924100 @default.
• W2918294521 hasIssue "3" @default.
• W2918294521 hasLocation W29182945211 @default.

• next